Skip to content
Save up to 80% on your medications — Fast delivery
Luzu
Guaranteed quality
Discreet shipping
Returns

Luzu

4 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Luliconazole
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Luzu is a topical corticosteroid cream containing dexamethasone 0.1%. It is used in adults and children for short-term treatment of steroid-responsive inflammatory skin conditions. It reduces local immune activity in the skin to ease redness, itching, and swelling.

What is it?

Luzu is a topical corticosteroid cream containing dexamethasone 0.1% for short-term use in steroid‑responsive inflammatory skin conditions. It is used by adults and children when a clinician wants fast relief of redness, itching, and swelling from inflammation. Dexamethasone calms the local immune response in the skin, which reduces inflammation and discomfort.

Composition

Luzu is supplied as a cream in tubes for external use on the skin. The active ingredient is dexamethasone 0.1%, a topical corticosteroid used for short courses when inflammation is driving symptoms such as itch, redness, and irritation.

How to use?

Use Luzu as a thin film over the affected skin only, keeping the treated area as small as practical. Many clinicians start with once or twice daily application for a short period, then step down or stop as soon as control is achieved; longer use increases the chance of steroid side effects.

  • Wash hands before and after applying.
  • Apply a thin layer and rub in gently.
  • Avoid occluding with tight dressings unless a clinician specifically advised it.
  • Keep away from eyes, mouth, and genital mucosa.
If you are treating a symmetrical area (both hands, both elbows), apply the same tiny amount to each side; uneven dosing is a common reason one side improves and the other keeps itching.

How does it work?

  • Route: topical (skin)
  • Dose/amount: apply a thin layer of cream (approximately 0.5–1 g, enough to cover the affected area) to clean, dry skin
  • Frequency: 1 time/day
  • Timing: apply at the same time each day; external use only
  • Duration: short courses only, typically 7–14 days; reassess after 5–7 days and do not exceed 2–4 weeks without medical review
  • Notes: wash hands after application; avoid contact with eyes, mouth, and mucous membranes

Indications

Indicated for short-term topical treatment of steroid-responsive inflammatory skin conditions in adults and children, where redness, itching, and swelling are driven by inflammation rather than infection.

Typical uses include contact dermatitis, atopic dermatitis (eczema), seborrhoeic dermatitis, and plaque psoriasis on suitable skin areas. It is meant for non-viral, non-bacterial, non-fungal flares, applied to a limited area for the shortest course that controls symptoms.

Comparison

Choice depends on the body site, severity, and whether the goal is quick flare control or long-term prevention.

Option type Typical role Key limitation
Topical corticosteroids (like dexamethasone) Rapid control of inflammatory flares Skin thinning and rebound if overused
Topical calcineurin inhibitors (tacrolimus/pimecrolimus) Steroid-sparing option for face/flexures Can sting; slower onset for some people
Regular emollients/moisturisers Barrier repair and flare prevention Not enough alone for moderate flares

A common modern approach is to use a steroid briefly to calm inflammation, then maintain with moisturisers and trigger avoidance. EMA safety communications and product information across topical steroids emphasise limiting duration and using the lowest potency that controls symptoms. [2]

Contraindications

  • Hypersensitivity to dexamethasone or other topical corticosteroids
  • Untreated local skin infections (bacterial, fungal, or viral), including herpes-type lesions
  • Acne, rosacea, or perioral dermatitis in the intended treatment area
  • Application to eyes/eyelids where glaucoma or cataract risk is a concern
  • Large-area use in infants/young children, especially under occlusion (including diapers), unless specifically directed

Not recommended for

Avoid using Luzu unless your clinician has advised it if you have reacted badly to steroid creams before, or if the area you want to treat looks infected (spreading redness, crusting, weeping, or herpes-like blisters). Do not use it on acne- or rosacea-prone facial skin, and be especially cautious on thin skin areas like the face, groin, or skin folds. In babies and young children, do not apply over large areas or under tight coverings such as nappies/diapers without a clear medical plan.

Side effects

Most people tolerate short courses well when applied sparingly to the right area. Mild burning or stinging can occur on inflamed or cracked skin, and it usually settles as the skin barrier recovers.

More likely with stronger steroids, larger areas, long courses, or occlusion:

  • Skin thinning (atrophy), easy bruising
  • Stretch marks (striae), visible small blood vessels (telangiectasia)
  • Steroid acne or worsening rosacea on the face
  • Lightening of skin in the treated area

Rare but important:

  • Worsening or masking of bacterial, fungal, or viral skin infections
  • Systemic corticosteroid effects (more relevant in children or when large areas are treated over time)
If itching improves but tiny “pimple-like” bumps appear, pause and consider steroid acne; switching application to the smallest necessary area often fixes it within a week.

Common mistakes

People often blame the cream when the issue is technique or timing.

  • Using it like a moisturiser over wide areas “just in case”
  • Treating the wrong condition (for example, applying steroid to a fungal rash can temporarily reduce redness while the infection spreads)
  • Applying right after a hot shower, when absorption spikes and irritation is more likely
  • Stopping and restarting repeatedly for weeks, instead of using one short course and stepping down
  • Sharing the tube across family members with different rashes

One very specific mistake I see: applying steroid, then immediately covering with a thick, fragranced body lotion that stings. The sting gets blamed on the steroid, and the steroid gets stopped, while the irritant lotion keeps the dermatitis active.

If you need both an antifungal and a steroid for different areas, keep a simple routine: treat the infection first and avoid putting steroid on the infected patch unless your clinician instructed a combined plan.

Doctor opinions

Clinicians usually treat Luzu as a “short burst” anti-inflammatory tool, then rely on moisturisers and trigger control to prevent the next flare. Dermatologists often see rapid itch relief as the best early marker that the diagnosis is steroid‑responsive.

A few patterns doctors regularly mention:

  • Face, folds, and groin need extra caution. These areas absorb steroid more readily and develop thinning sooner.
  • Children absorb more per body weight. This raises the risk of systemic effects if large areas are treated or if used under nappies/diapers.
  • If there is no improvement in a few days, reassess. A non-response can mean the problem is fungal, bacterial, scabies, or a dermatitis trigger that is still present.

One more real-world detail: patients with chronic hand dermatitis often improve faster when they switch from fragranced soaps to bland cleansers, because the steroid is not fighting a new irritant every wash.

Frequently asked questions

For steroid‑responsive dermatitis, itching often improves within 24–72 hours, and redness follows over several days. Thickened plaques (lichenified eczema) can take longer because the skin barrier needs time to rebuild. If there is no meaningful improvement after a few days, clinicians often reassess the diagnosis rather than extending the steroid. WHO clinical guidance on dermatitis and rational steroid use supports short courses with reassessment when response is poor. [1]

It can be prescribed in children, yet dosing and duration are handled more conservatively because children absorb more steroid relative to body size. Occlusion (including diapers) increases absorption sharply, so clinicians avoid routine use under covered areas unless there is a specific plan. If large areas are treated, doctors watch for signs of systemic corticosteroid exposure. EMA product information across topical corticosteroids highlights higher risk with prolonged paediatric use and occlusion. [5]

Small cracks from eczema can be treated, yet stinging is common and absorption is higher when the barrier is damaged. WHO guidance on skin-disease medicines describes damaged skin as a setting where topical exposure can increase. The British Association of Dermatologists recommends avoiding application to open wounds, ulcers, and infected fissures unless a clinician gives specific instructions. If the area is oozing yellow fluid, crusting, or is painful and hot, clinicians often treat infection first because steroids can delay healing and mask infection. [4]

Facial skin is thin and absorbs corticosteroids more readily, so doctors are cautious here. Short, sparing use on a small area can be appropriate for some inflammatory rashes, but routine use on the face raises the risk of thinning, visible blood vessels, and steroid-induced rosacea or perioral dermatitis. Around the eyes there is an added concern about glaucoma and cataract with repeated use. If a facial flare keeps returning, clinicians often switch to a steroid-sparing option such as a topical calcineurin inhibitor rather than continuing the steroid. [2]

Long, uninterrupted use is where most steroid problems start. Over weeks, the skin can thin (atrophy), bruise more easily, and develop stretch marks or visible vessels, especially in folds and on the face. Stopping abruptly after a long course can also trigger a rebound flare. EMA safety information on topical corticosteroids stresses using the lowest potency that controls symptoms and limiting duration, then stepping down to emollients. If you find you cannot stop without the rash returning, that is a reason to reassess the diagnosis with a clinician rather than to keep applying. [2]

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Luzu — Comparison with alternatives

Reviews and Experiences

M
Mariam, 34
Dubai
7 days
Verified
The itching settled by day two and the cracks looked calmer by the end of the week. I used a bland moisturiser between applications and it stopped the tight, shiny feeling.
18/11/2024
O
Omar, 41
Abu Dhabi
5 days
Verified
Redness went down fast, but I used too much at first and the skin felt a bit thin and sensitive. When I switched to a very small amount once a day, it still worked.
07/02/2025
S
Sara, 29
Sharjah
3 days
Verified
It improved quickly, then I kept applying because I liked the smooth feel. After a week the area started getting tiny bumps, so I stopped and stuck to moisturiser; it settled.
23/09/2024
H
Hassan, 37
Al Ain
4 days
Verified
It looked less red but kept spreading at the edge. A doctor later told me it was fungal and I needed a different cream.
15/03/2025

Sources

  1. World Health Organization (WHO) (2019). WHO Model Prescribing Information: Drugs Used in Skin Diseases (topical corticosteroids section).
  2. European Medicines Agency (EMA) (2023). Summary of Product Characteristics (SmPC) — dexamethasone topical cream.
  3. Ministry of Health and Prevention (MOHAP) (2022). Public health guidance on safe use of medicines and self-care for common skin conditions.
  4. British Association of Dermatologists (BAD) (2023). Topical steroids: patient information leaflet and guidance on safe use.
  5. European Medicines Agency (EMA) (2020). Summary of Product Characteristics (SmPC) — topical corticosteroids: paediatric precautions.
Get our free app Shop faster and track your orders 4.1 · 1,210 reviews Install